The US FDA's accelerated approval of Datroway (datopotamab deruxtecan) marks a notable advancement in the realm of lung cancer therapy. This approval is groundbreaking, as Datroway is the first TROP2-directed therapy sanctioned for lung cancer in the United States, specifically targeting a segment
Recent preclinical studies offer a glimmer of hope for millions battling formidable solid tumors. Nagoya University's breakthrough work in CAR-T cell therapy, focusing on the Eva1 protein, presents a potential paradigm shift. Amidst rising global cancer rates, these developments could redefine
In the rapidly advancing world of biopharmaceuticals, Ivan Kairatov stands as a beacon of knowledge. With his background in research and development and deep understanding of tech and innovation, Ivan has been pivotal in driving progress in the field. Today, he sheds light on new cancer vaccine
As the countdown begins for Cancer Research UK's Race for Life in Warrington, anticipation builds for this inspiring event slated for Victoria Park. This isn't just a race; it's a community gathering with deep significance, bringing people together to defy cancer and celebrate life. With options
Ivan Kairatov, with his extensive expertise in biopharmaceutical research and innovation, sheds light on the next generation of weight loss medications being developed. His insights provide a deeper understanding of the motivations and challenges behind this ambitious project, as well as the
Lung cancer remains one of the most lethal cancers worldwide, with survival rates hovering at a discouraging low despite advances in treatment. Among various types, lung squamous cell carcinoma (LUSC) poses unique challenges due to its aggressive nature and limited treatment options. The complexity
